Discover
ADXN
Addex Therapeutics Ltd
5.72
2 x 6.06
1 x 6.40
bid
ask
+
0.02
0.35%
2 @ 04:34 AM
5.99 +0.27 (4.72%)
| Ytd | -25.91% | |
| 1y | -37.83% |
5.72
day range
6.01
5.41
52 week range
12.05
| Open | 5.80 | Prev Close | 5.70 | Low | 5.72 | High | 6.01 | Mkt Cap | 7.24M |
| Vol | 1.29K | Avg Vol | 4.49K | EPS | -8.90 | P/E | N/A | Forward P/E | -159.83 |
| Beta | 1.87 | Short Ratio | 0.14 | Inst. Own | 0.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 6.55 | 200-d Avg | 7.62 | 1yr Est | 30.00 |
ADXN News
seekingalpha.com
Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Transcript
Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Transcript
benzinga.com
Addex Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript
Addex Therapeutics (NASDAQ:ADXN) reported first-quarter financial results on Thursday. The transcrip
benzinga.com
Earnings Scheduled For June 25, 2026
Companies Reporting Before The Bell • TD Synnex (NYSE:SNX) is projected to report quarterly earnings
benzinga.com
Addex Therapeutics Q1 EPS $(1.53) Down From $(1.33) YoY, Sales $10.214K Down From $78.928K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.53) per share. This is a 15.04 per
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session